Feedback / Questions
foscenvivint (PRI724) - PRISM Pharma, Ohara Pharma
http://clinicaltrials.gov/ct2/show/NCT06144086
Apr 29, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next